Skip to main content
MedPathMedPath Home
Clinical Trials/NCT04947475
NCT04947475
Completed
N/A

Project MATLINK: Development and Evaluation of a Screening, Brief Intervention, & Referral to Treatment (SBIRT) Program for Opioid Dependent Prisoners and Probationers Transitioning to the Community

Yale University3 sites in 3 countries835 target enrollmentJanuary 1, 2017
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsOpioid-use DisorderHIV InfectionsTuberculosisHepatitis CHepatitis BDepressionSyphilis

Overview

Phase
N/A
Intervention
Not specified
Conditions
Opioid-use Disorder
Sponsor
Yale University
Enrollment
835
Locations
3
Primary Endpoint
Enrollment on OAT
Status
Completed
Last Updated
11 months ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

The purpose of this study is to evaluate the efficacy a Screening, Brief Intervention, and Referral to Treatment (SBIRT) program for linking opioid dependent individuals currently incarcerated or in probation in Moldova, Kyrgyzstan, and Ukraine to opioid substitution therapy in the community after release or during their probation period.

Registry
clinicaltrials.gov
Start Date
January 1, 2017
End Date
April 30, 2023
Last Updated
11 months ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • •18 years of age or older
  • •Within 180 days of release or possible release (eligible for parole) to the community, but greater than 7 days to release to the community OR currently in probation.
  • •FOR THOSE IN PRISON: Relocating to a location within 30 km (approximately 60-minute commute) of the referred Narcology center. Each participant will be asked the address he/she is planning to reside under that will be immediately checked on the map to determine the travel time. A participant then will be asked if he/she would be willing to travel the distance to a particular OAT site. If a person does not meet this inclusion criterion, he/she will be referred to a local harm reduction center.
  • •Meets ICD-10 screening criteria for pre-incarceration opioid dependence
  • •FOR THOSE IN PROBATION:
  • •Living within 30 km of an OAT delivery site
  • •Not having received OAT in the last 15 days.
  • •Positive for OUD

Exclusion Criteria

  • •Pregnant or may become pregnant
  • •FOR THOSE IN PRISON: Will be released from prison in 7 days or less.

Outcomes

Primary Outcomes

Enrollment on OAT

Time Frame: 12 months

Total number of participants who enroll on OAT divided by the number of participants who underwent study procedures, per country.

Secondary Outcomes

  • OAT Importance(6 months)
  • OAT Knowledge(6 month)
  • OAT Attitudes(6 months)
  • Interest in OAT(6 months)
  • OAT Difficulty(6 months)

Study Sites (3)

Loading locations...

Similar Trials

Withdrawn
N/A
cSBI-M for Young Military PersonnelAlcohol AbuseTobacco DependenceSubstance Abuse
NCT01847300Boston Children's Hospital
Completed
N/A
Implementing Screening and Brief Interventions for Excessive Drinkers in Primary Health CareAlcohol-Related Disorders
NCT02968186Agrupamento de Centros de Saúde de Dão Lafões222
Unknown
N/A
Reducing the Duration of Untreated Psychosis in the United States: The Impact of Screening and Systematic CommunicationFirst Episode Psychosis (FEP)Clinical High Risk for Psychosis (CHR)
NCT05509998Icahn School of Medicine at Mount Sinai912
Completed
N/A
Reducing the Duration of Untreated Psychosis in the United StatesFirst Episode Psychosis (FEP)At Risk Mental State (ARMS)
NCT03369730Icahn School of Medicine at Mount Sinai94
Terminated
Early Phase 1
Brief Intervention and Referral to Treatment With Substance Use Disorders in the Emergency Room SettingSubstance Use
NCT01661517University of Alabama at Birmingham5,271